Mark Newman is President and CEO of Chemours Company.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Jun 23 | CC Chemours | Common Stock | Buy | Acquire P | No | No | 32.6299 | 7,661 | 249.98 k | 266,954.571 |
1 Mar 23 | CC Chemours | Common Stock | Grant | Acquire A | No | No | 0 | 43,053 | 0.00 | 259,171.898 |
1 Mar 23 | CC Chemours | Common Stock | Payment of exercise | Dispose F | No | No | 34.84 | 5,248 | 182.84 k | 216,118.898 |
1 Mar 23 | CC Chemours | Performance Stock Option Common Stock | Grant | Acquire A | No | No | 38.32 | 96,277 | 3.69 mm | 96,277 |
1 Mar 23 | CC Chemours | Stock Option Common Stock | Grant | Acquire A | No | No | 34.84 | 97,656 | 3.40 mm | 97,656 |
1 Mar 23 | CC Chemours | Performance Stock Option Common Stock | Grant | Acquire A | No | No | 38.32 | 100,200 | 3.84 mm | 100,200 |
10 Feb 23 | CC Chemours | Common Stock | Payment of exercise | Dispose F | No | No | 34.35 | 70,974 | 2.44 mm | 221,250.841 |
10 Feb 23 | CC Chemours | Common Stock | Grant | Acquire A | No | No | 0 | 147,540 | 0.00 | 292,224.841 |